September 2024 - December 2024
Jonathan Alder, PhD, and Aditi Gurkar, PhD // Pulmonary, Allergy, Critical Care, and Sleep Medicine and Geriatric Medicine/Aging Institute
SASP-ER platform to identify spatiotemporal senescence-associated secretome
R21 AG086744
Start Date: November 15, 2024
End Date: October 31, 2026
Total Annual Costs: $423,179
Sonya Borrero, MD // General Internal Medicine
CONVERGE
FISA Foundation
Start Date: January 1, 2025
End Date: December 31, 2026
Total Annual Costs: $79,780
Rhonda Brand, PhD // Gastroenterology, Hepatology and Nutrition
EMPOWER
RTI International
Start Date: September 30, 2024
End Date: September 29, 2025
Total Annual Costs: $6,826
Wei Du, MD, PhD // Malignant Hematology and Medical Oncology
A beneficial persistent DNA damage-induced immune response in aging
R56 HL169348
Start Date: September 17, 2024
End Date: August 31, 2025
Total Annual Costs: $709,654
John Evankovich, MD // Pulmonary, Allergy, Critical Care, and Sleep Medicine
Indole Metabolites as Xenobiotic Danger signals in Acute Lung Injury
R56 HL174649
Start Date: September 16, 2024
End Date: August 31, 2025
Total Annual Costs: $607,952
Sawa Ito, MD, PhD, and Warren Shlomchik, MD // Malignant Hematology and Medical Oncology
Phase 2 Study of Interferon-Gamma and Donor Lymphocyte Infusion for the Treatment of Relapsed Myeloid Malignancies after Allogeneic Stem Cell Transplantation
R01 FD008187 First R01 for Dr. Ito
Start Date: September 15, 2024
End Date: July 31, 2028
Total Annual Costs: $882,247
Paul Joudrey, MD (with Marynia Kolak) // General Internal Medicine
Localize Opioid Use Disorder (LOUD) response to increase medication access
R01 DA060183 First R01
Start Date: September 30, 2024
End Date: August 31, 2028
Total Annual Costs: $823,809
Ossama Kashlan, PhD // Renal-Electrolyte
Kashlan DCI Submission
Dialysis Clinic, Inc.
Start Date: January 1, 2025
End Date: December 31, 2025
Total Annual Costs: $49,998
Neil Kelly, MD, PhD // Cardiology/Vascular Medicine Institute
Circadian chronotype in pulmonary vascular disease
United Therapeutics Corporation
Start Date: January 1, 2025
End Date: December 31, 2025
Total Annual Costs: $90,909
Tamar Krishnamurti, PhD // General Internal Medicine
Implementing the Myana
Tuscarora Intermediate Unit 11
Start Date: September 30, 2024
End Date: September 29, 2025
Total Annual Costs: $377,229
Siamak Moghadam-Kia, MD, MPH // Rheumatology and Clinical Immunology
Meaningfulness of Total Improvement Score of ACR/E
Priovant Therapeutics
Start Date: September 30, 2024
End Date: September 29, 2025
Total Annual Costs: $83,415
Shari Rogal, MD, MPH, Matthew Chinman, PhD, and Charles Jonassaint, PhD (with Joie Acosta) // Gastroenterology, Hepatology and Nutrition and General Internal Medicine
University of Pittsburgh Health Promotion and Disease Prevention Research Center
CDC U48
Start Date: September 30, 2024
End Date: September 29, 2029
Total Annual Costs: $999,578
Ann-Marie Rosland, MD, MS // General Internal Medicine
Expanding the Role of Technology
Pittsburgh Foundation
Start Date: January 1, 2025
End Date: December 31, 2026
Total Annual Costs: $100,000
Sebastian Sattui, MD, MS // Rheumatology and Clinical Immunology
Prevalence and Impact of frailty in older adults with polymyalgia rheumatica
R03 AG082983
Start Date: September 15, 2024
End Date: August 31, 2026
Total Annual Costs: $339,038
Lokesh Sharma, PhD // Pulmonary, Allergy, Critical Care, and Sleep Medicine
Targeting Lysosomal Pathways to Improve Host Immunity
U.S. Army Medical Research Acquisition Activity
Start Date: December 1, 2024
End Date: November 30, 2028
Total Annual Costs: $249,914
Matthew Steinhauser, MD // Cardiology/Aging Institute
The Perturbalome: A Novel Molecular Signature for Human Resilience in Aging
Pittsburgh Foundation
Start Date: January 1, 2025
End Date: December 31, 2026
Total Annual Costs: $140,000